menu

Quintiles Library

Show Filters
Video
Where expert teams collaborate to create custom technology solutions that tackle some of healthcare's biggest challenges.
Video
At Quintiles, our employees who have nursing experience play a vital role in helping to improve patient outcomes. Five Quintiles leaders speak about how their nursing backgrounds help bring people and knowledge together for a healthier world.
Video
At Quintiles, we have hundreds of employees with nursing experience. As part of International Nurses Day, we celebrate those who play a vital role in bringing people and knowledge together for healthier world.
Video
Take a moment to watch this animated video, and you will get an engaging sense of how Quintiles' Precision Enrollment can help reduce your study start up by opening sites to studies only when they have a qualified patient. The right sites. The right patients. Within 21 days.
Fact Sheet
Clinical trial designs are becoming more complex, and there are increasing demands on clinical supply managers to move new therapies through the supply chain more efficiently and cost-effectively. A seamless and integrated supply chain strategy is critical to helping ensure that the patient receives the right treatment at the right time. Learn how you can execute your...
Read More
Article
According to Global Genes, more than 350 million people worldwide suffer from rare diseases. Unfortunately, according to the FDA’s Every Life Foundation, only around 5% of rare diseases have a FDA-approved treatment. Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, has worked on more than 230 rare disease...
Explore More
Press Release
All-stock transaction with combined 2015 revenue of $7.2 billion and combined equity market capitalization of $17.6 billion Broad range of healthcare information, technology and services solutions to drive efficiencies and insights across the entire life sciences product lifecycle, from R&D through commercial execution to real-world patient outcomes. ...
Read More
Press Release
Agreement to merge with IMS Health in all-stock transaction to create Quintiles IMS, an industry-leading information and technology-enabled healthcare services provider 8.4% constant currency service revenue growth compared to the first quarter of 2015 $0.89 diluted adjusted EPS representing 23.6% growth compared to the first quarter of 2015 Net new...
Read More
Fact Sheet
Healthcare systems are transforming from volume to value to outcomes. This shift fundamentally changes the way that biopharmaceutical companies approach drug development. The Quintiles Value & Outcomes Strategy Solution helps clients develop the evidence base to define the clinical, economic and humanistic profile of products. These are tailored to stakeholders’ needs to...
Read More
White Paper
Biopharma companies face significant complexity working in a global environment governed by rigorous regulatory and safety requirements that vary by market. To effectively manage your portfolio, you need to do more than simply meet regulatory requirements. By aligning all aspects of marketed product maintenance, including regulatory, safety and benefit-risk management,...
Explore More
Fact Sheet
As the demands of clinical development change, being nimble and adaptable becomes more critical. Meeting the evolving needs of multiple stakeholders ultimately determines the probability of success. And new agile development models are required to meet customer needs and increasing competitive intensity. Innovative technologies allow pharma companies to explore and pursue...
Read More
Infographic
Pharma companies are implementing RBM solutions – but may not have the experience and technology to do so effectively. Realizing the benefits of RBM requires a focus on change management and developing new workflows supported by integrating innovative technologies and multiple data sources. The solution: Quintiles Centralized Monitoring, offering a highly adaptive...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 22, 2016 – Quintiles, the world’s leading provider of biopharmaceutical services, announced today that it has been named to the 2016 CSO50 by IDG's CSO magazine. This award recognizes the company’s innovative identity management solution designed to expedite activities related to the delivery of clinical trials while simultaneously...
Read More
Presentation
Observational research is increasingly recognized as an important source of evidence for healthcare decision-making. Regulators, payers and providers assess observational study quality, and the International Society for Epidemiology provides Guidelines for Good Pharmacoepidemiology Practices (GPP). However, many studies are failing to meet required standards for design,...
Explore More
Fact Sheet
One of the major challenges in Product Development involves identifying focused, hard-to-find patient populations. With Quintiles Precision Enrollment, sites are designed to start up within 21 days, offering the right trials to the right patients in a streamlined manner. Finding patients as quickly as possible is key to managing the cost and time pressures associated with...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 18, 2016 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its first quarter 2016 financial results Tuesday, May 3, 2016 prior to its quarterly earnings call at 8:00 a.m. EDT. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors....
Read More
Article
Integrate Channels to Unleash Better Outcomes Multichannel is no longer an industry buzz word, rather, it’s a methodology for success amidst a tangled marketplace. Like the links of a chain, an integrated multichannel strategy connects channels, content, and customers in a straight line aimed directly at helping patients. The industry has moved reluctantly beyond...
Explore More
Article
Observational research-evaluating outcomes in patients in a naturalistic rather than an experimental setting-has the potential to answer many research questions. But in order to do so effectively, researchers must select "the right research approach for the right question." Doing so requires thorough evaluation of feasibility of delivery, specialized operational...
Explore More
Article
Posted with permission from RAPS Regulatory Focus.   Chew, KT and Rao, M. “World Drug Firsts from Asia (Outside Japan).” Regulatory Focus. March 2016. Regulatory Affairs Professionals Society. 
Explore More
Article
Posted with permission from RAPS Regulatory Focus.   KT, Chew and Meenakshi, R. “Drug Development in Asia: Scattering the Mist.” Regulatory Focus. February 2016. Regulatory Affairs Professionals Society.
Explore More